Identification of Clostridium difficile RT078 From Patients and Environmental Surfaces in Zhejiang Province, China
To the Editor-Clostridium difficile has been a predominant cause of nosocomial diarrhea in North America and Europe, especially after the emergence of PCR-ribotypes 027 and 078. However, less emphasis is placed on the surveillance and control of C. difficile infection (CDI) in China. Li et al 1 isolated a novel binary toxin strain of C. difficile from a hospitalized patient and mentioned that cases of ribotype 078 had not previously been reported in China. Here, we report 8 isolates that were identified as C. difficile ribotype 078 in a surveillance program in Zhejiang Province, China.
Our study was conducted at 3 tertiary hospitals (hospitals A, B, and C) from June 2013 to December 2014. A total of 98 unduplicated isolates of C. difficile from 61 clinical patients and 37 environmental surfaces were identified. A multiple polymerase chain reaction (multi-PCR) assay was used to amplify 16S rDNA, tcdA, tcdB, cdtA, and cdtB genes. The overall incidence of binary toxin-positive strains was 8.2%; 4 isolates (7%) were collected from patients, and 4 (11%) isolates were collected from environmental surfaces ( Table 1) . In hospital B, 2 (22%) of the detected binary toxin strains were obtained from patients and 1 strain (33%) was isolated from an environmental surface. In hospital C, 2 strains (11%) were identified from patients and 3 strains (9%) were obtained from environmental surfaces. No hyper-toxigenic strain was detected in hospital A. According to the tcdC gene sequence, all 8 isolates were identified as ribotype 078, with a mutation point at position 184 and a Δ39-bp deletion (Figure 1) .
Previously, a few Asian countries and regions have reported the emergence of C. difficile ribotype 078, including Kuwait, 2 South Korea, 3 Iran, 4 Japan, 5 and Taiwan. 6 The present study is the first to identify ribotype 078 cases not only from patients but also from environmental surfaces in China. Compared with neighboring Japan and Korea, the prevalence of CDI in China remains unclear, mainly due to a lack of awareness in the healthcare system. 7 Many clinicians are accustomed to diagnosing patients with antibiotic-associated diarrhea by experience rather than by the results of stool cultures. In addition, although enzyme-linked immunosorbent assay (ELISA) has been used routinely to detect C. difficile in most tertiary hospitals in China, this method has a low sensitivity and does not trace the binary toxin strain. For these reasons, CDI, especially CDI caused by binary-toxin strains, may be severely underestimated in China.
China has the largest population with the trend of aging accompanied by antibiotic misuse, indicating the potential for epidemics of CDI. Medical practitioners should pay more attention to this global infection, as both C. difficile ribotypes 
